Katherine E. Brighty

656 total citations
14 papers, 417 citations indexed

About

Katherine E. Brighty is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Katherine E. Brighty has authored 14 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Katherine E. Brighty's work include Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Katherine E. Brighty is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Katherine E. Brighty collaborates with scholars based in United States. Katherine E. Brighty's co-authors include Thomas D. Gootz, Deepak Dalvie, Chin H. Chen, S L Haskell, Joyce A. Sutcliffe, Paul R. McGuirk, Anis A. Khan, Jack S. Remington, Fausto G. Araujo and Jonathan L. Doty and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Organic Chemistry and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Katherine E. Brighty

14 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine E. Brighty United States	8	197	153	141	127	88	14	417
Toshiaki Kamimura Japan	10	167 0.8×	130 0.8×	116 0.8×	115 0.9×	54 0.6×	28	363
Yasuhiro Nishitani Japan	14	180 0.9×	206 1.3×	325 2.3×	166 1.3×	42 0.5×	26	599
Terutaka Hashizume Japan	13	290 1.5×	134 0.9×	149 1.1×	340 2.7×	89 1.0×	30	569
MICHAEL J. BASKER United States	12	274 1.4×	124 0.8×	117 0.8×	244 1.9×	81 0.9×	35	503
MASATOMO FUKASAWA Japan	11	390 2.0×	105 0.7×	132 0.9×	332 2.6×	96 1.1×	23	544
Eric Desarbre France	15	212 1.1×	182 1.2×	316 2.2×	340 2.7×	69 0.8×	26	720
Prasad Deshpande India	12	179 0.9×	205 1.3×	314 2.2×	167 1.3×	59 0.7×	28	595
Masako Otsuki Japan	13	211 1.1×	107 0.7×	35 0.2×	154 1.2×	88 1.0×	31	350
Yozo Todo Japan	9	175 0.9×	85 0.6×	77 0.5×	100 0.8×	180 2.0×	26	416
Paola Dozzo United States	9	133 0.7×	182 1.2×	107 0.8×	191 1.5×	54 0.6×	10	446

Countries citing papers authored by Katherine E. Brighty

Since Specialization

Citations

This map shows the geographic impact of Katherine E. Brighty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Brighty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Brighty more than expected).

Fields of papers citing papers by Katherine E. Brighty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Brighty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Brighty. The network helps show where Katherine E. Brighty may publish in the future.

Co-authorship network of co-authors of Katherine E. Brighty

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Brighty. A scholar is included among the top collaborators of Katherine E. Brighty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Brighty. Katherine E. Brighty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wishka, Donn G., Katherine E. Brighty, Kathleen A. Farley, et al.. (2011). An Asymmetric Synthesis of (2S,5S)-5-Substituted Azepane-2-Carboxylate Derivatives. The Journal of Organic Chemistry. 76(6). 1937–1940. 14 indexed citations

Visser, Michael, Kevin D. Freeman‐Cook, Steven J. Brickner, et al.. (2010). Synthesis and biological evaluation of novel hygromycin A antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 20(22). 6730–6734. 4 indexed citations

Le, Phuong, Steven J. Brickner, Katherine E. Brighty, et al.. (2010). The discovery and structure–activity relationships leading to CE-156811, a difluorophenyl cyclopropyl fluoroether: A novel potent antibacterial analog derived from hygromycin A. Bioorganic & Medicinal Chemistry Letters. 21(1). 276–279. 3 indexed citations

Brighty, Katherine E., et al.. (2000). Synthesis of (1α,5α,6α)-6-Amino-3-azabicyclo[3.1.0]hexane, a Novel Achiral Diamine. Synlett. 1996(11). 1097–1099. 27 indexed citations

Khan, Anis A., Fausto G. Araujo, Katherine E. Brighty, Thomas D. Gootz, & Jack S. Remington. (1999). Anti- Toxoplasma gondii Activities and Structure-Activity Relationships of Novel Fluoroquinolones Related to Trovafloxacin. Antimicrobial Agents and Chemotherapy. 43(7). 1783–1787. 22 indexed citations

Brighty, Katherine E. & Thomas D. Gootz. (1997). The chemistry and biological profile of trovafloxacin. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 1–14. 108 indexed citations

Gootz, Thomas D. & Katherine E. Brighty. (1996). Fluoroquinolone antibacterials: SAR, mechanism of action, resistance, and clinical aspects. Medicinal Research Reviews. 16(5). 433–486. 147 indexed citations

Reiter, Lawrence A., et al.. (1996). Synthesis of Mono N-Substituted Guanylthioureas. Synthetic Communications. 26(7). 1423–1429. 2 indexed citations

Dalvie, Deepak, et al.. (1996). Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.. Drug Metabolism and Disposition. 24(11). 1231–1240. 23 indexed citations

10.

Gootz, Thomas D., et al.. (1994). In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial. Diagnostic Microbiology and Infectious Disease. 19(4). 235–243. 37 indexed citations

11.

Desai, Manoj C., et al.. (1993). Novel fragmentation of 3-lithio-3,6-dihydro-1,2-oxazines: Synthesis of 2,5-dihydro-2-furanylamines. Tetrahedron Letters. 34(6). 961–962. 12 indexed citations

12.

Wender, Paul A. & Katherine E. Brighty. (1988). Studies on tumor promoters: V. Complementary 1,4-stereocontrol in phorboid cycloheptene synthesis via the divinylcyclopropane rearrangement. Tetrahedron Letters. 29(51). 6741–6744. 4 indexed citations

13.

Chen, Chin H., et al.. (1981). Synthesis of phosphalilolidine and phosphajulolidine. The Journal of Organic Chemistry. 46(2). 361–367. 7 indexed citations

14.

Chen, Chin H. & Katherine E. Brighty. (1980). A new phosphine-sulfides-to-phosphine-oxides exchange reaction. Tetrahedron Letters. 21(46). 4421–4424. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact